* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Mouse anti-D4-GDI - Thermo Fisher Scientific
Survey
Document related concepts
G protein–coupled receptor wikipedia , lookup
Magnesium transporter wikipedia , lookup
Protein (nutrient) wikipedia , lookup
Immunoprecipitation wikipedia , lookup
Protein moonlighting wikipedia , lookup
Interactome wikipedia , lookup
Nuclear magnetic resonance spectroscopy of proteins wikipedia , lookup
List of types of proteins wikipedia , lookup
Protein adsorption wikipedia , lookup
Protein–protein interaction wikipedia , lookup
Transcript
Qty: 100 μg/200 μl Mouse anti-D4-GDI Catalog No. 35-9900 Lot No. Mouse anti-D4-GDI FORM This monoclonal antibody is supplied as a 200 μl aliquot at a concentration of 0.5 mg/ml in PBS, pH 7.4, containing 0.1% sodium azide. This antibody is highly purified from mouse ascites by protein A chromatography. CLONE: 2H7F3 ISOTYPE: IgG1 IMMUNOGEN Recombinant D4-GDI fusion protein. SPECIFICITY This antibody reacts with the full-length form of the human D4-GDI protein. Cross-reactivity with Rho-GDI has not been tested. On Western blots, this antibody identifies a band at 28 kDa. REACTIVITY Reactivity has been confirmed with human Jurkat cell lysates. Sample Human Mouse Immunogen ELISA ND ND +++ Western Blotting +++ ND N/A (Excellent +++, Good++, Poor +, No reactivity 0, Not applicable N/A, Not Determined ND) USAGE Working concentrations for specific applications should be determined by the investigator. Appropriate concentrations will be affected by several factors, including secondary antibody affinity, antigen concentration, sensitivity of detection method, temperature and length of incubations, etc. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product. ELISA : 0.1 – 1.0 μg/mL Western Blotting: 1-3 μg/mL STORAGE Store at 2-8°C for up to one month. Store at –20°C for long-term storage. Avoid repeated freezing and thawing. (cont’d) www.invitrogen.com Invitrogen Corporation • 1600 Faraday Avenue • Carlsbad • CA 92008 • Tel: 800.955.6288 • E-mail: [email protected] PI35-9900 Rev. 7/07 Copyright 2005, Zymed Laboratories DCC-06-0084 (35-9900 cont’d) BACKGROUND Guanine nucleotide dissociation inhibitor (GDI) proteins exert negative regulatory effects on the Rho family of GTPases (Rho, Rac, Cdc42) by inhibiting the dissociation of GDP, thereby maintaining GTPases in their inactive, cytosolic form. The Rho family of GTPases is involved in a diverse variety of cellular functions, including cell signaling, proliferation, cytoskeletal organization, and secretion.1-6 These proteins also regulate specific aspects of inflammatory activity, such as motility, 3 production of pro-inflammatory cytokines, and generation of toxic oxygen metabolites. D4-GDI (or LY-GDI) was originally identified as a hematopoeitic cell-abundant homolog of Rho-GDI.7,8 Unlike Rho-GDI, which is ubiquitously expressed, D4-GDI is predominantly expressed by lymphoid and myeloid cells. The amino acid 9 sequence of D4-GDI predicts a ~23 kDa protein; however, the full-length protein migrates at ~28 kDa by SDS-PAGE. Studies have demonstrated that D4-GDI is a proteolytic substrate for caspase-3 and –8, and that cleavage by either caspase-3 or –8 can produce de-regulation of Rho-GTPases.9,10 Release of Rho-GTPases from the inhibitory constraints of D4-GDI likely results in cytoskeletal alterations, activation of the stress-activated protein kinases p38 and c-Jun, and enhanced production of toxic oxygen metabolites. REFERENCES 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. Hall A. Ann Rev Cell Biol 10:31-54, 1994. Tapon N, Hall A. Curr Opin Cell Biol 9:86-92, 1997. Dharmawardhane S, Bokoch GM. Curr Opin Hematol 4:12-18, 1997. Ridley AJ. Curr Biol 6:1256-1264, 1996. Denhardt DT. Biochem J 318:729-747, 1996. Symons M. Trends Biochem Sci 21:178-181, 1996. Lelias JM, et al. PNAS 90:1479-1483, 1993. Scherle P, et al. PNAS 90:7568-7572, 1993. Na S, et al. J Biol Chem 271:11209-11213, 1996. Danley DE, et al. J Immunol 157:500-503, 1996. RELATED PRODUCTS Product Rabbit anti-Rho-GDIα Mouse anti-Caspase-3 Rabbit anti-Caspase-3 Mouse anti-Caspase-8 Rabbit anti-Caspase-8 Mouse anti-Caspase-2 Mouse anti-Caspase-7 Mouse anti-Caspase-9 Rabbit anti-Caspase-9 Mouse anti-p38-α MAP Kinase Mouse anti-p38-β2 MAP Kinase Clone/PAD* NGA-25 4-1-18 Z-R32 4-1-20 FP2 4C12A3 1-1-11 96-2-22 AM9 p38-3F11 p38-11A5 Cat. No. 51-1000 35-1600 71-6400 35-1700 51-1100 33-9200 35-1000 35-0700 51-7600 33-1300 33-8700 ® Protein A rec-Protein G Sepharose 4B ® Sepharose 4B 10-1041 10-1241 *PAD: Polyclonal Antibody Designation Conjugate Purified FITC TRITC Cy™3 Cy™5 HRP AP Biotin ZyMAX™ Goat x Rabbit IgG (H+L) 81-6100 81-6111 81-6114 81-6115 81-6116 81-6120 81-6122 81-6140 ZyMAX™ Goat x Mouse IgG (H+L) 81-6500 81-6511 81-6514 81-6515 81-6516 81-6520 81-6522 81-6540 Zymed® and ZyMAX™ are trademarks of Zymed Laboratories Inc. Cy™ is a trademark of Amersham Biosciences Ltd. Sepharose® is a registered trademark of Pharmacia LKB. For Research Use Only LF021025 www.invitrogen.com Invitrogen Corporation • 1600 Faraday Avenue • Carlsbad • CA 92008 • Tel: 800.955.6288 • E-mail: [email protected] PI35-9900 Rev. 7/07 Copyright 2005, Zymed Laboratories DCC-06-0084